ABCB1 and HIV infectious disease: Therefore, nanotherapeutic strategies with P-glycoprotein efflux inhibitors have been extensively investigated as a Trojan horse approach to enhancing intracellular concentrations of antiretroviral drugs that are P-glycoprotein substrates, ultimately improving HIV infection eradication.